Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers. The organism carried the vanA resistance gene, which may have come from the vancomycin-resistant Enterococcus faecalis that was also isolated from the patient, who had received vancomycin for several weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing rates of oxacillin-resistant S aureus or MRSA isolates in both hospital and community settings and the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“and is especially prevalent in North America.6,138,139”
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Diagnostic molecular microbiology : principles and applications
Persing, D. H. (1993) · ASM Press eBooks · Cited by 1,311
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Self-citation(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Arthur, M., Molinas, C., Depardieu, F., & Courvalin, P. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.117-127.1993 · Cited by 603
Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus
Bannerman, T. L., Hancock, G. A., Tenover, F. C., & Miller, J. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.551-555.1995 · Cited by 550
Self-citationCharacterization of glycopeptide-resistant enterococci from U.S. hospitals
Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M., & Tenover, F. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2311 · Cited by 395
Self-citationApplication of pulsed-field gel electrophoresis to molecular epidemiology
Maslow, J. N. (1993) · Medical Entomology and Zoology · Cited by 382
Research works printed but not linked: 7
- 1997, MMWR Morb Mortal Wkly Rep, 46, 624
- 2000, MMWR Morb Mortal Wkly Rep, 48, 1165
- 2002, MMWR Morb Mortal Wkly Rep, 51, 565
- Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:264-82.
- 2001, MMWR Morb Mortal Wkly Rep, 50, 1
- 1995, MMWR Morb Mortal Wkly Rep, 44, 1
- 1997, MMWR Morb Mortal Wkly Rep, 46, 626
Cited by
Items 701–800 of 1,000
Ekhtiari-Sadegh, S., Samani, S., Barneh, F., Dashtbin, S., Shokrgozar, M. A., & Bagheri, K. P. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1385001 · Cited by 12
“However, the emergence of vancomycin -resistant S. aureus (VRSA) (Hiramatsu et al., 1997; Chang et al., 2003; Cong et al., 2020) and even resistant strains to its alternative antibiotics, daptomycin and linezolid (Kawasuji et al., 2023), has led to treatment failure in hospitalized patients.”
BackgroundBone grafts as vancomycin carriers in local therapy of resistant infections
Melicherčík, P., Jahoda, D., Nyč, O., Klapková, E., BARTÁK, V., Landor, I., POKORNÝ, D., Judl, T., & Sosna, A. (2012) · Folia Microbiologica · doi:10.1007/s12223-011-0093-2 · Cited by 11
Boumis, E., Gesu, G. P., Menichetti, F., Ranieri, V. M., Rinaldi, M., Suter, F., Nicastri, E., Lauria, F., Carosi, G., Moroni, M., et al. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.05.006 · Cited by 12
“aureus.(3,4) Vancomycin resistance is common in many nosocomial settings, and now also viridans streptococci, once a leading cause of subacute IE, are increasingly acquiring resistance to penicillin and other b-lactam antibiotics.”
BackgroundVancomycin for treatment of invasive, multi-drug resistantStaphylococcus aureusinfections
Pope, S. D., & Roecker, A. M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.9.1245 · Cited by 11
“The plasmid encoding for vanA genes was identified from all three VRSA cases [106-109].”
BackgroundEkrami, A., Montazeri, E. A., Kaydani, G. A., & Shokoohizadeh, L. (2015) · Europe PMC (PubMed Central) · Cited by 11
Brossier, F., Lefrançois, S., Paute, J., Gouot, A., Golmard, J., Chaı̈bi, P., Pautas, É., Berigaud, S., Drieux, L., Jarlier, V., et al. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.06.020 · Cited by 11
Tiedemann, M. T., Pinter, T. B. J., & Stillman, M. J. (2012) · Metallomics · doi:10.1039/c2mt20067h · Cited by 12
Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Bermuda
Akpaka, P. E., Kissoon, S., Wilson, C., Jayaratne, P., Smith, A., & Golding, G. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171317 · Cited by 11
Johnston, T., Tyne, D. V., Chen, R. F., Fawzi, N. L., Kwon, B., Kelso, M. J., Gilmore, M. S., & Mylonakis, E. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-25571-w · Cited by 12
Factors affecting susceptibility of Staphylococcus aureus to antibacterial agents
Kawada‐Matsuo, M., & Komatsuzawa, H. (2012) · Journal of Oral Biosciences · doi:10.1016/j.job.2012.04.001 · Cited by 11
“Recently, strains highly resistant to vancomycin that contain the enterococcal vanA gene have also emerged [5] The mechanism of the resistance of these strains is clearly distinct from that found in VISA strains.”
BackgroundInfluentialOn-resin cyclization and antimicrobial activity of Laterocidin and its analogues
Qin, C., Xu, C., Zhang, R., Niu, W., & Shang, X. (2009) · Tetrahedron Letters · doi:10.1016/j.tetlet.2009.11.007 · Cited by 11
Cha, C., An, H.-K., & Kim, J. U. (2010) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2010.30.2.138 · Cited by 11
“더욱이 vanA 유전자 를 가진 반코마이신 내성 Staphylococcus aureus의 출현으로 VRE 감염관리의 중요성이 강조되고 있다[22].”
Revazishvili, T., Bakanidze, L. G., Gomelauri, T., Zhgenti, E., Chanturia, G., Kekelidze, M., Rajanna, C., Kreger, A. S., & Sulakvelidze, A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01030-06 · Cited by 11
“been reported (8, 18, 46) in Japan, the United States, Europe”
BackgroundBeckmann, A., Hüttel, S., Schmitt, V., Müller, R., & Stadler, M. (2017) · Microbial Cell Factories · doi:10.1186/s12934-017-0756-z · Cited by 13
“were isolated, followed by reports of vancomycin-resistant ones in 2003 [6, 7].”
BackgroundWang, W.-Y., Yang, S., Wu, Y., Shen, X., & Chen, S. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-8983-8 · Cited by 11
Mazumdar, A., & Adam, V. (2021) · Journal of Molecular and Clinical Medicine · doi:10.31083/j.jmcm.2021.01.208 · Cited by 11
Göktaş, S., Kurtoğlu, M. G., Sakarya, Y., Uğurluoğlu, C., Özçimen, M., Sakarya, R., Alpfidan, İ., Ivacık, I. S., Erdoğan, E., & Bukus, A. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0052 · Cited by 11
“3 16 However, there has been an increase in drug resistance of the MRSA infection 17–22 ; as a result, there is a need for alternative anti-MRSA agents.”
Sigurðardóttir, B., Berg, J. V., Hu, J., Alamu, J., McNutt, L., Diekema, D. J., & Herwaldt, L. A. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/507278 · Cited by 11
“The prevalence of vancomycin-resistant enterococci (VRE) that the vanA gene had been transferred from VRE to colonization and infection continues to increase among pa- MRSA.(7,8) tients in hospitals.”
BackgroundStaphylococcus aureus: Times, They Are A-Changin'
Craven, D. E., & Shapiro, D. S. (2005) · Clinical Infectious Diseases · doi:10.1086/498907 · Cited by 11
“aureus (VRSA) isolates (MIC, 16–32 mg/mL) appeared [3].”
Badgujar, P., Malik, A. K., Mehata, A. K., Setia, A., Verma, N., Randhave, N. V., Shukla, V. N., Kande, V., Singh, P., Tiwari, P., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135532 · Cited by 13
Shahraki, P. K., Kiani, R., Siavash, M., & Bemani, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-85147-3 · Cited by 10
Moreillon, P., Bizzini, A., Giddey, M., Vouillamoz, J., & Entenza, J. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr521 · Cited by 10
Vancomycin Resistance in Ocular Infections
Gupta, M., Durand, M. L., & Sobrin, L. (2011) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e31822d67c7 · Cited by 10
“The first case of VRSA was reported in 2002 in the United States.(18) Since then, fewer than 20 cases of VRSA have been reported worldwide.”
BackgroundInfluentialTabuchi, F., Matsumoto, Y., Ishii, M., Tatsuno, K., Okazaki, M., Sato, T., Moriya, K., & Sekimizu, K. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.56 · Cited by 12
Antimicrobial Resistance: An Overview
Shah, S. N., Bhat, M. A., Bhat, M. A., & Jan, A. T. (2024) · Springer eBooks · doi:10.1007/978-981-97-2023-1_1 · Cited by 13
Self-citationKaleem, F. (2012) · African Journal of Microbiology Research · doi:10.5897/ajmr11.787 · Cited by 10
“First clinical isolate of vancomycin resistant S. aureus (VRSA) was reported from a patient in Michigan (USA) in year 2002 (Chang et al., 2003).”
BackgroundAnwar, M. M., Reizian, A. M. E., Kholy, A. M. E., Sayed, I. E., & Hafez, M. K. (2016) · Indian Journal of Surgery · doi:10.1007/s12262-016-1566-y · Cited by 10
Orscheln, R. C., Shinefield, H. R., & Geme, J. W. S. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160537-0/50019-0 · Cited by 11
Vaccines and Immunotherapy for Staphylococcal Infections
Patti, J. M. (2005) · The International Journal of Artificial Organs · doi:10.1177/039139880502801113 · Cited by 10
Yanagihara, K., Seki, M., Izumikawa, K., Higashiyama, Y., Miyazaki, Y., Hirakata, Y., Tomono, K., Mizuta, Y., Tsukamoto, K., & Kohno, S. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.026 · Cited by 10
Viana, A. S., Tótola, L. P. D. V., & Figueiredo, A. M. S. (2024) · Antibiotics · doi:10.3390/antibiotics13090893 · Cited by 9
“Interestingly, the first vancomycin-resistant S. aureus (VRSA) strain was found in Michigan, USA, in 2002 [40,41].”
BackgroundZhang, Z., Pan, Z., Fan, L., Su, Y., & Fei, J. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00381 · Cited by 9
Neto, A. M. B., Rabelo, M. A., Lima, J. L. D. C., Loibman, S. O., Leal, N. C., & Maciel, M. A. V. (2018) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0159-2017 · Cited by 9
Cao, R., Su, H., Wei, Z., He, Z., Pan, T. S., Li, Y., & Sun, B. (2024) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2024.151624 · Cited by 9
Lee, J. Y. H., & Howden, B. P. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1041924 · Cited by 9
“Fortunately, reports of VRSA have remained infrequent to date, with 13 cases reported in the US [17,18,22] and sporadic cases reported in Kolkata [23], Iran [24], Portugal [25] and Brazil [26].”
BackgroundEntenza, J. M., Haldimann, A., Giddey, M., Lociuro, S., Hawser, S., & Moreillon, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-09 · Cited by 9
“However, the emergence of vancomycin-intermediate and vancomycin-resistant MRSA in several countries (2, 6, 17) further reduces treatment options and indicates that last-resort therapy with vancomycin could become obsolete sooner or later.”
BackgroundA New Target for Staphylococcus aureus Associated With Keratitis
Suzuki, T. (2011) · Cornea · doi:10.1097/ico.0b013e3182282100 · Cited by 9
“aureus has recently been reported to have acquired resistance to vancomycin, a drug of last resort.(5,6) Because of the advance of antibiotic resistance among S.”
BackgroundRazeghi, M., Saffarian, P., & Goudarzi, M. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100411 · Cited by 9
STAPHYLOCOCCUS AUREUS INFECTIONS (COAGULASE-POSITIVE STAPHYLOCOCCI)
Kaplan, S. L., Hultén, K. G., & Mason, E. O. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50096-0 · Cited by 11
Tan, X., Xie, S., Jin, X. L., Zhu, R., Wei, S., Song, Y., Xie, X., Wang, R., Li, L., Wang, M., et al. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022013 · Cited by 9
Jorge León, Q., Aponte, J. J., Rojas, R., Cuadra, D. ́., Ayala, N., Tomás, G., & Guerrero, M. (2011) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2011.282.489 · Cited by 9
“Por más de dos décadas se le controló con vancomicina; sin embargo, han emergido cepas resistentes a este antibiótico (9,10).”
Prevalence of Vancomycin-Resistant Enterococcus in Prenatal Screening Cultures
Miller, M. B., Allen, S. L., Mangum, M. E., Doutova, A., & Gilligan, P. H. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.855-857.2004 · Cited by 9
Garvin, K. L., Kildow, B. J., Hewlett, A. L., Hartman, C. W., & Fey, P. D. (2023) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.22.00792 · Cited by 9
Hénard, S., Gendrin, V., Simon, L., Jouzeau, N., Vernier, N., Thiolet, J., Coignard, B., & Rabaud, C. (2011) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2011.01.004 · Cited by 9
Two Cases of Vancomycin-intermediate Staphylococcus aureus Isolated from Joint Tissue or Wound
Hong, K. H., Park, J. S., & Kim, E.-C. (2008) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2008.28.6.444 · Cited by 9
Optimizing Therapy for MRSA Pneumonia
Skrupky, L. P., Micek, S. T., & Kollef, M. H. (2007) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2007-996408 · Cited by 9
Selective digestive decontamination and antibiotic resistance: A balancing act *
Bonten, M. J. M., & Grundmann, H. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000080491.46005.3f · Cited by 9
McDonald, J. R., Engemann, J. J., Kaye, K. S., & Sexton, D. J. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/503504 · Cited by 9
“aureus.(1) The article by Warren et al.”
Resistance to Glycopeptides in Gram-Positive Pathogens
Fraimow, H. S., & Courvalin, P. M. (2014) · ASM Press eBooks · doi:10.1128/9781555816513.ch63 · Cited by 9
Taha, S. M., El-Aziz, N. K. A., Abdelkhalek, A., Peț, I., Ahmadi, M., & El-Nabtity, S. (2024) · Antioxidants · doi:10.3390/antiox13040428 · Cited by 11
“S. aureus is a leading human pathogen that causes a wide range of clinical symptoms ranging from relatively mild skin and soft tissue infections to serious and even fatal systemic illnesses [9].”
BackgroundRahimkhani, M., & Rajabi, Z. (2024) · Proceedings of the National Academy of Sciences India Section B Biological Sciences · doi:10.1007/s40011-024-01558-8 · Cited by 8
“In a case report study in 2003, a VRSA with MIC >32 μg per milliliter was identified [29].”
Epidemiology of Healthcare‐Associated Staphylococcus Aureus Infections
Simor, A. E., & Loeb, M. B. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch14 · Cited by 9
Facility-Level Correlates of Antimicrobial Use in Nursing Homes
Loeb, M. B., McGeer, A., Simor, A. E., Walter, S. D., Bradley, S., Low, D. E., & Moss, L. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502373 · Cited by 9
A reductive coupling strategy towards ripostatin A
Schleicher, K. D., & Jamison, T. F. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.175 · Cited by 8
Herrera, M., Gregorio, S. D., Fernández, S., Posse, G., Mollerach, M. E., & Conza, J. D. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0131-7 · Cited by 8
Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
Lin, C., Wang, J.-H., Lin, K.-H., Ho, Y., & Ho, C. (2018) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_145_17 · Cited by 12
“staphylococcus aureus The resistance mechanisms of VRSA originated from S. aureus isolates gaining the vancomycin-resistant determinant vanA from VRE [31,32].”
BackgroundInfluentialMoller, A. G., Petit, R. A., Davis, M. H., & Read, T. D. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02728-22 · Cited by 9
Low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus and how to test it
Hawkey, P. M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03094.x · Cited by 8
Matsuda, Y., Kato, H., Ono, E., Kikuchi, K., Muraoka, M., Takagi, K., Imanishi, K., Itoh, S., Itoh, T., Ogawa, T., et al. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00071.x · Cited by 8
Zuo, G., Li, Y., Wang, G.-C., Li, Z., & Han, J. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0844-5 · Cited by 8
“In conclusions, this study demonstrated that Ber and M-Ber enhanced the in vitro inhibitory efficacy of AZM and LEV, which showed potential for combinatory therapy of patients infected with MRSA and warrant further pharmacological investigation.”
BackgroundResultInfluentialSweih, N. A., Mokaddas, E. M., Jamal, W. Y., Phillips, O. A., & Rotimi, V. O. (2005) · Journal of Chemotherapy · doi:10.1179/joc.2005.17.6.607 · Cited by 8
Nagy, G. G., Várvölgyi, C., & Paragh, G. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29509 · Cited by 8
Ranganathan, V. (2015) · Cited by 18
Ekkelenkamp, M. B., Rooijakkers, S. H. M., & Bonten, M. J. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00165-9 · Cited by 9
Chemotherapeutic Strategies for Combating Staphylococcus aureus Infections
Sharma, N., Chhillar, A. K., Dahiya, S., Punia, A., Choudhary, P., Gulia, P., Behl, A., & Dangi, M. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210402150325 · Cited by 11
Comparando inativação fotodinâmica e antimicrobianos
Melo, W., & Perussi, J. R. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 8
A review of the current place of glycopeptides in turkish medical practice
Erdem, H., & Öncül, O. (2007) · Current Therapeutic Research · doi:10.1016/j.curtheres.2007.03.001 · Cited by 8
Subanovic, M., Frawley, D., Tierney, C., Velasco‐Torrijos, T., & Walsh, F. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00147-7 · Cited by 9
“Themostimportantpathogenmethicillin-resistant S. aureus (MRSA) is usually treated with vancomycin; however, vancomycin-resistant S. aureus (VRSA) has emerged 12 – 14 .”
Gul, H., Gul, H., Ahmad, P., Hayat, A., Rehman, M. U., Moussa, I. M., & Elansary, H. O. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1241995 · Cited by 7
Absence of vancomycin-resistance genes in Staphylococcus aureus isolated from potable water
Abulreesh, H. H. (2014) · Journal of Public Health and Epidemiology · doi:10.5897/jphe2013.0606 · Cited by 7
Antimicrobial Susceptibility Testing Methods for Bacterial Pathogens
Tenover, F. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_32 · Cited by 8
Self-citationXiao, B., Kiani, S., Toushmalani, R., Zangeneh, A., Zangeneh, M. M., Goorani, S., & Morovvati, H. (2023) · Materials Express · doi:10.1166/mex.2023.2543 · Cited by 7
Antibiotic Resistance in Staphylococcus Species of Animal Origin
de Souza, M. M. S., Coelho, S. D. M. D. O., Pereira, I. A., Soares, L. D. C., Rocha, B., & Coelho, I. D. S. (2012) · InTech eBooks · doi:10.5772/28518 · Cited by 7
“reported for many countries including the United States, Japan, Australia, France, Scotland, Brazil, South Korea, Hong Kong, South Africa, Thailand, Israel, and others (Bierbaum et al. 1999; Chang et al., 2003; Denis et al. 2002; Ferraz et al., 2000 Gemmell, 2004; Howden et al., 2010; Kim et al., 2000; Perichon & Cour…”
BackgroundIsolation and identification of bacterial pathogens from wounds of diabetic patients
Scheffold, C., Daniel, E., & Sowmiya, S. (2013) · Cited by 7
Sangeda, R. Z., Sam, L., Anne, W. M., Peter, G. W., & Samuel, K. (2017) · African Journal of Microbiology Research · doi:10.5897/ajmr2017.8481 · Cited by 7
“…enterococci to S. aureus under laboratory conditions (Noble et al., 1992) and after reports of staphylococcal isolates resistant to vancomycin in some countries (Hiramatsu et al., 1997a, b; Sieradzki et al., 1999; Chang et al., 2003; Whitener et al., 2004; Palazzo et al., 2005; Lee et al., 2015).”
BackgroundHäring, A., Heudorf, U., Exner, M., Pitten, F.-A., Waidmann, O., Hack, D., Kempf, V. A. J., & Reinheimer, C. (2020) · PubMed Central · doi:10.3205/dgkh000348 · Cited by 7
“aureus [40], might be misinterpreted as a new nosocomial acquisition.”
BackgroundJaneoo, S., Kaur, H., Kaul, G., Akhir, A., Chopra, S., Banerjee, S., Reenu, R., Kumar, V., & Kumar, R. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130924 · Cited by 9
Yanagihara, K., Ohnishi, Y., Morinaga, Y., Nakamura, S., Kurihara, S., Seki, M., Izumikawa, K., Kakeya, H., Yamamoto, Y., Yamada, Y., et al. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.04.030 · Cited by 7
Risk factors associated with MRSA
Gupta, S., Mishra, B., Thankur, A., Dogra, V., Loomba, P. S., Jain, M., & Bhargava, A. (2018) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v33i3.9 · Cited by 7
Emerging Antimicrobial-Resistant Infections
Roos, K. L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.10.1512 · Cited by 7
“This gene is acquired from vancomycinresistant enterococci by conjugative transfer.(16) Staphylococci are the most common causative organisms of craniotomy bone flap infections, osteomyelitis as a complication of craniotomy, postoperative epidural abscess, and CSF shunt infections.”
BackgroundRosario-Rosado, R. V., René, A. A., & Jones, B. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502372 · Cited by 9
Multidrug-resistant Organisms and Healthcare-associated Infections
Kim, M. (2011) · Hanyang Medical Reviews · doi:10.7599/hmr.2011.31.3.141 · Cited by 7
“미국에서 처음 보고된 vanA 양성 VRSA는 VRE와 MRSA가 함께 분리되던 환자에서 출현하여, VRSA 가 VRE 와 MRSA의 장기간에 걸친 접촉과정에서 vanA 유전자가 전 파되어 발생한 것으로 추정된다[42,43].”
Methicillin Resistant Staphylococcus aureus - Post surgical Infections in Egyptian Hospital
El‐Moez, S. I. A., Dorgham, S. M., & El-Aziz, E. A. (2011) · Cited by 8
Molecular Detection of Antibacterial Drug Resistance
Abbott, A. N., & Fang, F. C. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch77 · Cited by 6
ENDOGENOUS ENDOPHTHALMITIS DUE TO CLINICALLY VANCOMYCIN-RESISTANT STAPHYLOCOCCUS AUREUS
Dedania, V. S., Hale, B. P., & Bhatnagar, P. (2014) · Retinal Cases & Brief Reports · doi:10.1097/icb.0000000000000082 · Cited by 6
“aureus was reported in 2002 from an indwelling catheter tip.(2) The Center for Disease Control (CDC) currently defines vancomycin-susceptible S.”
BackgroundChiang, P.-C., Wu, T., Su, J., Huang, Y., Chiu, Y.-P., Chia, J., Kuo, A.-J., & Su, L. (2007) · PubMed · Cited by 6
Silva‐Santana, G., & Lenzi Almeida, K. C. (2016) · Journal of Clinical & Experimental Pathology · doi:10.4172/2161-0681.1000283 · Cited by 6
“The recommended antimicrobial therapy for infections caused by these isolates has been, so far, Vancomycin, Daptomycin and Linezolid [33-35]; however, Vancomycin-resistant strains (VRSA) have already been reported [36-38].”
BackgroundÇomoğlu, Ş. (2018) · Haydarpasa Numune Training and Research Hospital Medical Journal · doi:10.14744/hnhj.2018.30085 · Cited by 6
Simjee, S., Jensen, L. B. ̄. ⁄., Donabedian, S. M., & Zervos, M. (2019) · ASM Press eBooks · doi:10.1128/9781555817534.ch18 · Cited by 6
Zarifian, A., Sadeghian, A., Sadeghian, H., Ghazvini, K., & Safdari, H. (2012) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.14468 · Cited by 6
Frequency and antibiogram of vancomycin resistant enterococcus in a tertiary care hospital.
Babar, N., Usman, J., Munir, T., Gill, M. M., Anjum, R., Gilani, M., & Latif, M. (2014) · PubMed · Cited by 6
Yamaguchi, T., Ando, R., Matsumoto, T., Ishii, Y., & Tateda, K. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s209591 · Cited by 7
“MRSA has acquired resistance to practically all the antibiotics brought into clinical use in the past 50 years, including vancomycin (VAN).(7,8) According to the minimum inhibitory concentrations (MICs) of VAN, S.”
BackgroundBoudrioua, A., Li, Y., Hartke, A., & Giraud, C. (2020) · FEMS Microbiology Letters · doi:10.1093/femsle/fnaa062 · Cited by 6
Daum, R. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00117-3 · Cited by 6
Yılmaz, M., & Şeker, E. (2022) · Etlik Veteriner Mikrobiyoloji Dergisi · doi:10.35864/evmd.1008728 · Cited by 6
Antibacterial susceptibility testing in the clinical laboratory
Joyce, M., & Woods, C. W. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.001 · Cited by 9
Makhathini, S. S., Omolo, C. A., Kiruri, L. W., Walvekar, P., Devnarain, N., Mocktar, C., & Govender, T. (2022) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2022.105241 · Cited by 6
Treatment and recurrence management of staphylococcal infections: community-acquired MRSA
Kale-Pradhan, P. B., & Johnson, L. B. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.909 · Cited by 7
Antibiotic Resistance in the Intensive Care Unit
Vilà, J., & Marco, F. (2007) · Springer eBooks · doi:10.1007/978-3-540-34406-3_19 · Cited by 6
Ammerlaan, H., & Bonten, M. J. M. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01627.x · Cited by 9
Metadata
- Authors
- Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., Cardo, D., & Fridkin, S. K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Michigan Department of Health and Human Services (US)
- Wayne State University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1342-1347
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2068037991
- Semantic Scholar
- f0afb59f819a65ada63076a36807f63502c4437d
- Cited by
- 1,095
- References
- 18
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 24 · 2023: 28 · 2022: 24 · 2021: 35 · 2020: 29 · 2019: 39 · 2018: 28 · 2017: 29 · 2016: 28 · 2015: 55 · 2014: 54 · 2013: 51 · 2012: 65
- FWCI
- 54.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- vancomycin-resistant Staphylococcus aureus, vanA gene, vancomycin resistance, diabetes mellitus, peripheral vascular disease, foot ulcer, vancomycin-resistant Enterococcus faecalis, antibiotic resistance transfer, catheter-related infection
- MeSH terms
- Adult, Catheterization, Debridement, Female, Renal Dialysis, Humans, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Contact Tracing, Diabetic Foot, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.